基于证据的更新关于抗胆固醇药物用于药物诱导的运动障碍
Nora Vanegas-Arroyave1, Stanley N Caroff2,3, Leslie Citrome4
1Department of Neurology, Baylor College of Medicine, 7200 Cambridge Street, Suite 9A, Houston, TX, 77030, USA. Nora.VanegasArroyave@bcm.edu.
对药物诱导运动障碍 (DIMD) 的抗胆固醇使用因病情而异. 虽然它们对药物诱导的帕金森症 (DIP) 和 dystonia 有效,但由于风险和证据有限,不建议用于晚期动力障碍症 (TD),阿卡西西亚或NMS.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 运动障碍 运动障碍
背景情况:
- 药物诱导的运动障碍 (DIMD) 是多巴胺受体阻断剂 (DRBA) 的副作用,通常是抗精神病药物.
- 关键的DIMD包括药物诱导的帕金森症 (DIP), dystonia, akathisia,晚期动症 (TD) 和神经乱性恶性综合征 (NMS).
- 术语"extrapyramidal症状"是非特定的,可以导致不适当的抗胆固醇药的使用.
结论:
- 在DIMD管理中适当使用抗胆类药物需要仔细考虑特定疾病,有效性的证据和可能造成严重不良影响.
- 抗胆固醇药物带有风险,包括外围 (例如,尿液保留) 和中心 (例如,认知障碍) 影响,特别是在老年人中.
- 当处方时,抗胆固醇药应该以最低有效剂量使用,持续时间有限,并在停止后逐渐逐渐减少.
更多相关视频
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
